Celgene Receives Positive CHMP Opinion to Extend REVLIMIDĂ‚ Lenalidomide for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

Posted: December 19th, 2014  |  Company/topic: Celgene
Website:
Celgene International Srl a wholly owned subsidiary of Celgene Corporation NASDAQ CELG today announced that the European Medicines Agency's EMA Committee for Medicinal Products for Human U…

Shire chief: We want to be like Gilead, Biogen and Celgene

Posted: December 12th, 2014  |  Company/topic: Celgene
Website:
On the rebound after a dalliance with AbbVie and its $55 billion red herring, Shire CEO Flemming Ornskov is back on the offensive, talking up his company's potential to rub elbows with the biggest amo…

Celgene ends stellar week with positive Abraxane data

Posted: December 11th, 2014  |  Company/topic: Celgene
Website:
Celgene ends stellar week with positive Abraxane data…

Celgene ends stellar week with positive Abraxane data

Posted: December 11th, 2014  |  Company/topic: Celgene
Website:
Celgene ends stellar week with positive Abraxane data…